Skip to main content
Veterinary Medicines

Ursomutin 25 % Granulat

Authorised
  • Tiamulin hydrogen fumarate

Product identification

Medicine name:
Ursomutin 25 % Granulat
Active substance:
  • Tiamulin hydrogen fumarate
Target species:
  • Chicken
  • Pig
  • Turkey
Route of administration:
  • In-feed use
  • In drinking water use

Product details

Active substance and strength:
  • Tiamulin hydrogen fumarate
    25.00
    gram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Granules
Withdrawal period by route of administration:
  • In-feed use
    • Chicken
      • Meat and offal
        3
        day
      • Egg
        no withdrawal period
    • Pig
      • Meat and offal
        5
        day
    • Turkey
      • Meat and offal
        3
        day
      • Egg
        no withdrawal period
  • In drinking water use
    • Chicken
      • Meat and offal
        3
        day
      • Egg
        no withdrawal period
    • Pig
      • Meat and offal
        5
        day
    • Turkey
      • Meat and offal
        3
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Serumwerk Bernburg AG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Serumwerk Bernburg AG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 400826.00.00
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 2/09/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."